申请人:Gruenenthal GmbH
公开号:US08084470B2
公开(公告)日:2011-12-27
Substituted nicotinamide compounds corresponding to formula I
a process for their preparation, pharmaceutical compositions containing these compounds, and the use thereof for the treatment or inhibition conditions such as pain, epilepsy, migraine, anxiety states, or urinary incontinence.
本发明涉及与式Ia相对应的替代烟酰胺化合物及其制备方法,含有这些化合物的药物组合物,以及将其用于治疗或抑制疼痛、癫痫、偏头痛、焦虑状态或尿失禁等症状的用途。